StockData
Organogenesis Holdings Inc. logo

Organogenesis Holdings Inc. (ORGO) stock

ORGONasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 10/30
$0.81+0.01 (+1.06%)

Close on Nov 17, 2026Market cap $104.43MP/E –Yield –

Organogenesis r&d expenses

Research and development expenses are spending on new products and technology.

Organogenesis's R&D Expenses for the twelve months ending Jun 30, 2026 was $56.97M, up 32.8% year over year. For fiscal 2025 it was $44.54M, down 11.4% from the year before. The highest annual figure on record is $50.27M in fiscal 2024.

Annual r&d expenses

PeriodPeriod endValueChange
FY2025Dec 31, 2025$44.54M-11.4%
FY2024Dec 31, 2024$50.27M+13.3%
FY2023Dec 31, 2023$44.38M+11.6%
FY2022Dec 31, 2022$39.76M+29.3%
FY2021Dec 31, 2021$30.74M+53.1%
FY2020Dec 31, 2020$20.09M+35.7%
FY2019Dec 31, 2019$14.80M+37.8%
FY2018Dec 31, 2018$10.74M+18.5%
FY2017Dec 31, 2017$9.07M+44.4%
FY2016Dec 31, 2016$6.28M–

Quarterly r&d expenses

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$18.30M+76.0%
Q1 FY2026Mar 31, 2026$15.16M+42.5%
Q4 FY2025Dec 31, 2025$10.29M-10.8%
Q3 FY2025Sep 30, 2025$13.22M+27.8%
Q2 FY2025Jun 30, 2025$10.40M-33.3%
Q1 FY2025Mar 31, 2025$10.64M-16.9%
Q4 FY2024Dec 31, 2024$11.53M-2.0%
Q3 FY2024Sep 30, 2024$10.34M-1.2%
Q2 FY2024Jun 30, 2024$15.59M+42.5%
Q1 FY2024Mar 31, 2024$12.81M+14.4%
Q4 FY2023Dec 31, 2023$11.77M+3.3%
Q3 FY2023Sep 30, 2023$10.47M+9.3%
Q2 FY2023Jun 30, 2023$10.94M+7.2%
Q1 FY2023Mar 31, 2023$11.20M+30.5%
Q4 FY2022Dec 31, 2022$11.40M+38.0%
Q3 FY2022Sep 30, 2022$9.58M+6.9%
Q2 FY2022Jun 30, 2022$10.21M+39.4%
Q1 FY2022Mar 31, 2022$8.59M+38.3%
Q4 FY2021Dec 31, 2021$8.26M+31.1%
Q3 FY2021Sep 30, 2021$8.95M+141.4%
Q2 FY2021Jun 30, 2021$7.32M+56.8%
Q1 FY2021Mar 31, 2021$6.21M+14.8%
Q4 FY2020Dec 31, 2020$6.30M+73.0%
Q3 FY2020Sep 30, 2020$3.71M-5.5%
Q2 FY2020Jun 30, 2020$4.67M+20.8%
Q1 FY2020Mar 31, 2020$5.41M+60.5%
Q4 FY2019Dec 31, 2019$3.64M+17.8%
Q3 FY2019Sep 30, 2019$3.92M+41.2%
Q2 FY2019Jun 30, 2019$3.86M+88.7%
Q1 FY2019Mar 31, 2019$3.37M+19.4%
Q4 FY2018Dec 31, 2018$3.09M+13.0%
Q3 FY2018Sep 30, 2018$2.78M+19.5%
Q2 FY2018Jun 30, 2018$2.05M-16.5%
Q1 FY2018Mar 31, 2018$2.82M+82.1%
Q4 FY2017Dec 31, 2017$2.74M–
Q3 FY2017Sep 30, 2017$2.33M–
Q2 FY2017Jun 30, 2017$2.45M–
Q1 FY2017Mar 31, 2017$1.55M–

More Organogenesis figures

See a number that looks wrong?